Ying Li

Ying Li currently serves as the Director of Real World Evidence (RWE) and Advanced Analytics at Regeneron Pharmaceuticals, Inc., a position held since August 2020, after progressing from Associate Director, RWE. Prior to this role, Ying Li worked at IBM from September 2015 to August 2020 as a Research Staff Member in the Center for Computational Health, focusing on drug-related analytic methods. Ying Li's academic background includes a Ph.D. in Biomedical Information from Columbia University, with additional degrees in Biomedical Engineering from Zhejiang University and Huazhong University of Science and Technology. Throughout the educational journey, Ying Li gained practical experience through roles such as a summer intern at GlaxoSmithKline and participation in AMIA as a student member.